🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A bit more on adult onset type 1 diabetes. Going to post a few videos on this #atypicaldiabetes Starting here:

Spending a bit of time reflecting on good friends, good fortune, and what Osler said.

I often get asked about UTIs with SGLT2i which were not observed in the trials. Great to see this study showing that in routine clinical care, SGLT2i initiation is not associated with ⬆️ risk of UTI compared with GLP-1RA initiation. diabetesjournals.org/care/article-a…

*NEWS* Highlighting this on 2 counts to the world of #Diabetes 1. Continued outstanding work from DSNforumUK on #Technology 2. An ask to follow John Pemberton who is doing outstanding work in this field (& wider) - welcome to X Use/ RT/ Cascade as needed Shivani Misra

I'm not joking when i say this. Authors of papers about the effect of a specific diet, should disclose as a potential COI if they follow that specific diet. I honestly think if you intrinsically BELIEVE in a specific diet because you have benefitted personally from it, you may

Higher consumption of sugar-sweetened beverages and artificially sweetened beverages associated with a higher risk of T2 #diabetes Even in those who are physically active - a link.springer.com/article/10.100…

Thanks for sharing Daniel J Drucker Hard to believe it’s 20 years since the first GLP-1 drug was approved for type 2 diabetes — the same year I graduated med school! 🙈🙈 Lots of fear-mongering on here about long-term use of meds like Ozempic, but we’ve been using GLP-1s in

Metformin for osteoarthritis now ! Significant reduction in pain vs placebo jamanetwork.com/journals/jama/…

GRADE Trial Weight gain associated with worse glycaemic control & increased risk of cardiovascular and kidney outcomes independent of treatment. diabetesjournals.org/care/article/d…

📢 New from EASO Our latest infographic explores the health impacts of obesity in males and females. Clear visuals for use in prevention, care & research. Download: easo.org/new-infographi… #PublicHealth

Association between statin use & T2 diabetes Increases with longer duration of use Varies by types of statins Risk lowered with healthy lifestyle link.springer.com/article/10.100… Mamas A. Mamas

Presented at #ECO2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial results: nej.md/44ZeMPz EASLnews

Malaysian street food and a catch up Shivani Misra 💕

One key takeaway from the session is expressed so well in this slide, presented by COMs cochair Dror Dicker: Treatment of #obesity is about improving health, wellbeing and prolonging lives. It goes beyond weightloss #ECO2025 #EASOed

More needs to be done to tackle this disease earlier! linkedin.com/posts/docholme…

Amazing and congrats Uncle K 🤩Prof Kamlesh Khunti

Nutritional priorities to support GLP-1 therapy for obesity onlinelibrary.wiley.com/doi/10.1002/ob…

A practical review of HbA1c and when it should, or should not, be used in diagnosis, monitoring and setting treatment targets: view Jane Diggle’s comprehensive review here: eu1.hubs.ly/H0kKH1J0

📣The Primary Care cardio-renal-metabolic philosophy of care is clear when it comes to #CVRM conditions - we have no favourites, we focus on them all 📣 See below for our updated Medscape #hacks on #CKD. We do not want to dialyse, thus we must strategize! #wholepersoncare #CKD

Study that will change guideline recommendations In people with both chronic kidney disease and type 2 diabetes Initial therapy with finerenone + empagliflozin Greater reduction in the urinary albumin-to-creatinine ratio than either treatment alone. nejm.org/doi/full/10.10…